Profile change history

What changed for Larazotide?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Larazotide identity.

13Total events
13Record additions
0Version changes
5Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 13 connected records →

Showing the latest 13 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 16, 2026.

Record added

ClinicalTrials.gov record NCT00362856

PeptideScanner retained ClinicalTrials.gov record NCT00362856 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-12, and PeptideScanner's reviewed identity mapping was larazotide.

PeptideScanner change date
November 16, 2026
Cited source date
September 12, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00386165

PeptideScanner retained ClinicalTrials.gov record NCT00386165 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-11, and PeptideScanner's reviewed identity mapping was larazotide.

PeptideScanner change date
November 16, 2026
Cited source date
September 11, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00386490

PeptideScanner retained ClinicalTrials.gov record NCT00386490 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-12, and PeptideScanner's reviewed identity mapping was larazotide.

PeptideScanner change date
November 16, 2026
Cited source date
September 12, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00492960

PeptideScanner retained ClinicalTrials.gov record NCT00492960 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-20, and PeptideScanner's reviewed identity mapping was larazotide.

PeptideScanner change date
November 16, 2026
Cited source date
September 20, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00620451

PeptideScanner retained ClinicalTrials.gov record NCT00620451 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-20, and PeptideScanner's reviewed identity mapping was larazotide.

PeptideScanner change date
November 16, 2026
Cited source date
September 20, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00889473

PeptideScanner retained ClinicalTrials.gov record NCT00889473 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-20, and PeptideScanner's reviewed identity mapping was larazotide.

PeptideScanner change date
November 16, 2026
Cited source date
September 20, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01396213

PeptideScanner retained ClinicalTrials.gov record NCT01396213 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-20, and PeptideScanner's reviewed identity mapping was larazotide.

PeptideScanner change date
November 16, 2026
Cited source date
September 20, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05747534

PeptideScanner retained ClinicalTrials.gov record NCT05747534 at 2026-11-16T01:45:58.486Z. Its registry update date was 2026-08-18, and PeptideScanner's reviewed identity mapping was larazotide.

PeptideScanner change date
November 16, 2026
Cited source date
August 18, 2026
Evidence lane
Clinical trials
Record added

Commentary: larazotide acetate - an exciting new development for coeliac patients?

PubMed lists PMID 23336683 in Alimentary pharmacology & therapeutics as Journal Article, Comment, with publication-date metadata of 2013-02 (month precision). PeptideScanner associated the retained record with the identity slug larazotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 2, 2018
Evidence lane
Literature metadata
Record added

Commentary: larazotide acetate - an exciting new development for coeliac patients? Authors' reply.

PubMed lists PMID 23336684 in Alimentary pharmacology & therapeutics as Journal Article, Comment, with publication-date metadata of 2013-02 (month precision). PeptideScanner associated the retained record with the identity slug larazotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 2, 2018
Evidence lane
Literature metadata
Record added

[Larazotide as an option in case of failure of a gluten-free diet].

PubMed lists PMID 26983338 in Medizinische Monatsschrift fur Pharmazeuten as Journal Article, with publication-date metadata of 2016-02 (month precision). PeptideScanner associated the retained record with the identity slug larazotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
August 27, 2021
Evidence lane
Literature metadata
Record added

Zonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series.

PubMed lists PMID 35211683 in Critical care explorations as Journal Article, with publication-date metadata of 2022-02-18 (day precision). PeptideScanner associated the retained record with the identity slug larazotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
March 17, 2022
Evidence lane
Literature metadata
Record added

Viral spike antigen clearance and augmented recovery in children with post-COVID multisystem inflammatory syndrome treated with larazotide.

PubMed lists PMID 40737433 in Science translational medicine as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase II, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural, with publication-date metadata of 2025-07-30 (day precision). PeptideScanner associated the retained record with the identity slug larazotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
August 12, 2026
Evidence lane
Literature metadata